Related Experiment Video
Updated: Jul 2, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Optimizing antibiotic management for patients with acute appendicitis: A quality improvement study
Jason Beckermann1, Maria E Linnaus1, Hayden Swartz2
1General and Trauma Surgery, Mayo Clinic Health System-Northwest Wisconsin region, Eau Claire, WI.
Background:
To decrease surgical site infections after appendectomy for acute appendicitis, preoperative broad-spectrum antibiotics are often used in clinical practice. However, this treatment strategy has come under scrutiny because of increasing rates of antibiotic-resistant infections.
Methods:
The aim of this multisite quality improvement project was to decrease the treatment of uncomplicated acute appendicitis with piperacillin-tazobactam without increasing the rate of surgical site infections. Our quality improvement intervention had 2 distinct components: (1) updating electronic health record orders to encourage preoperative administration of narrow-spectrum antibiotics and (2) educating surgeons and emergency department clinicians about selecting appropriate antibiotic therapy for acute appendicitis. Patient demographics, clinical characteristics, and outcomes were compared 6 months before and after implementation of the quality improvement intervention.
Results:
A total of 352 laparoscopic appendectomies were performed during the 6-month preintervention period, and 369 were performed during the 6-month postintervention period. The preintervention period and postintervention period groups had similar baseline demographics, vital signs, and laboratory test values. The rate of preoperative piperacillin-tazobactam administration significantly decreased after the intervention (51.4% preintervention period vs 20.1% postintervention period, P < .001). The rate of surgical site infections was similar in both groups (superficial surgical site infections = 1.4% preintervention period vs 0.8% postintervention period, P = .50; deep surgical site infections = 1.1% preintervention period vs 0.0% postintervention period, P = .06; and organ space surgical site infections = 3.1% preintervention period vs 3.0% postintervention period, P > .99). Rates of 30-day readmission, reoperation, and Clostridioides difficile infection also did not differ between groups.
Conclusion:
Our quality improvement intervention successfully decreased piperacillin-tazobactam administration without increasing the rate of surgical site infections in patients with acute appendicitis.
Insights
This study reduced piperacillin-tazobactam use for appendicitis by updating antibiotic orders and educating clinicians. Surgical site infection rates remained stable, demonstrating a successful quality improvement intervention.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Quality Improvement
Background:
- Preoperative broad-spectrum antibiotics are standard for appendectomy but face scrutiny due to rising antibiotic resistance.
- The use of piperacillin-tazobactam for acute appendicitis is a particular concern.
- Developing strategies to optimize antibiotic use is crucial for patient outcomes and antimicrobial stewardship.
Purpose of the Study:
- To decrease the use of piperacillin-tazobactam in uncomplicated acute appendicitis.
- To maintain or decrease surgical site infection (SSI) rates following appendectomy.
- To implement a quality improvement project focused on appropriate antibiotic selection.
Main Methods:
- A multisite quality improvement project was conducted.
- Intervention components included updating electronic health record orders and clinician education on antibiotic selection.
- Outcomes were compared between the 6-month preintervention and 6-month postintervention periods.
Main Results:
- Piperacillin-tazobactam use decreased significantly from 51.4% to 20.1% postintervention (P < .001).
- Surgical site infection rates (superficial, deep, organ space) did not increase.
- Rates of 30-day readmission, reoperation, and Clostridioides difficile infection remained similar between groups.
Conclusions:
- The quality improvement intervention effectively reduced piperacillin-tazobactam administration for acute appendicitis.
- This approach successfully lowered targeted antibiotic use without compromising surgical site infection rates.
- The findings support optimizing antibiotic selection in appendicitis management to combat resistance.
More Related Videos
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Related Concept Videos
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Antibiotic Selection
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Tonsillitis II: Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...